Vericel (VCEL) Change in Cash (2010 - 2026)
Vericel (VCEL) posted Change in Cash of $16.1 million for Q2 2026, up 74.54% sequentially from $9.2 million in Q1 2026, and up 1842.32% YoY from $827000.0 in Q2 2025.
Analysis
Vericel (VCEL) Change in Cash (2010 - 2026) Analysis & Trends
Vericel has reported Change in Cash for 17 years, with the latest figure at $16.1 million in Q2 2026.
- Quarterly Change in Cash rose 1842.32% year-over-year to $16.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $44.8 million (up 858.23% YoY) and the FY2025 annual result came in at $15.0 million, up 927.9% from the prior year.
- Change in Cash advanced to $16.1 million in Q2 2026 per VCEL's latest filing, from $9.2 million in the prior quarter.
- Over five years, Change in Cash peaked at $19.9 million in Q3 2025 and troughed at -$16.1 million in Q1 2024.
- A 5-year average of $3.2 million and a median of $3.1 million in 2022 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2023 and 2024: Change in Cash soared 2174.18% in 2023, then plunged 249.75% in 2024.
- Over 5 years, Change in Cash stood at -$14.1 million in 2022, then jumped by 123.36% to $3.3 million in 2023, then surged by 344.75% to $14.7 million in 2024, then slumped by 102.12% to -$311000.0 in 2025, then soared by 5264.95% to $16.1 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered $16.1 million, $9.2 million, and -$311000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -185.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 427.25 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.94 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn | 16.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.06 Mn |
| Mar 31, 2026 | 9.20 Mn |
| Dec 31, 2025 | -311,000.00 |
| Sep 30, 2025 | 19.87 Mn |
| Jun 30, 2025 | 827,000.00 |
| Mar 31, 2025 | -5.34 Mn |
| Dec 31, 2024 | 14.70 Mn |
| Sep 30, 2024 | -5.50 Mn |
| Jun 30, 2024 | 5.11 Mn |
| Mar 31, 2024 | -16.12 Mn |
| Dec 31, 2023 | 3.31 Mn |
| Sep 30, 2023 | 12.74 Mn |
| Jun 30, 2023 | 8.98 Mn |
| Mar 31, 2023 | 10.77 Mn |
| Dec 31, 2022 | -14.15 Mn |
| Sep 30, 2022 | 2.98 Mn |
| Jun 30, 2022 | 395,000.00 |
| Mar 31, 2022 | -6.70 Mn |
| Dec 31, 2021 | 13.78 Mn |
| Sep 30, 2021 | 2.79 Mn |